KER-1003

N/A

Report date: 2025/01/26 17:08:58

Base Information

Drug NameKER-1003

Drug Alias NameKI-1003 (Kereos)NanoBees (Kereos)cytolytic peptide nanoparticles (Kereos)melittin Apis melliferamelittin-loaded nanoparticles (Kereos) +[7]

ClassificationBiologics > Protein drugs > ToxinNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionIntegrin alpha-V/beta-3 modulators

TargetsIntegrin alpha-V/beta-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKereos Inc

China Registration ClassN/A

Develop Information

Active CompaniesKereos Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A